rs10911741 - MCRIP2P2 - LINC01350
Magnitude 2.8 · 1 study on file
Reported associations
-
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci. - Human molecular genetics (2025) · Byun J, Han Y, Choi J, Sun R, Shaw VR, Zhu C, Xiao X, Lusk C, Badr H, Lee HS, Jang HJ, Li Y, Lim H, Long E, Liu Y, Kachuri L, Walsh KM, Wiencke JK, Albanes D, Lam S, Tardon A, Neuhouser ML, Barnett MJ, Chen C, Bojesen S, Brenner H, Landi MT, Johansson M, Risch A, Wichmann HE, Bickeböller H, Christiani DC, Rennert G, Arnold S, Field JK, Shete S, Le Marchand L, Liu G, Andrew AS, Zienolddiny S, Grankvist K, Johansson M, Caporaso N, Taylor F, Lazarus P, Schabath MB, Aldrich MC, Patel A, Lin X, Zanetti KA, Harris CC, Chanock S, McKay J, Schwartz AG, Hung RJ, Amos CI · PubMed 40341939
Despite lung cancer affecting all races and ethnicities, disparities are observed in incidence and mortality rates among different ethnic groups in the United States. Non-Hispanic African Americans had a high incidence rate of lung cancer at 55.8 per 100 000 people, as well as the highest death rate at 37.2 per 100 000 people from 2016 to 2020. While previous genome-wide association studies (GWAS) have identified over 45 susceptibility risk loci that influence lung cancer development, few GWAS have investigated the etiology of lung cancer in African Americans. To address this gap in knowledge, we conducted GWAS of lung cancer focused on studying African Americans, comprising 2267 lung cancer cases and 4264 controls. We identified three loci associated with lung cancer, one with lung ad
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Discuss genetic lung adenocarcinoma risk with healthcare provider Moderate
Variant rs10911741 T allele associated with increased lung adenocarcinoma susceptibility; clinical significance and family screening implications warrant professional assessment
Schedule appointment to review genetic findings and personalized risk assessment
Screening
-
Discuss lung cancer screening approach with doctor Moderate
Carriers of rs10911741 T allele have approximately 32 percent increased lung adenocarcinoma risk; screening strategy should be tailored to this elevated baseline risk
Bring genetic results to healthcare provider; discuss screening timing and modality